SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-072810
Filing Date
2018-12-13
Accepted
2018-12-13 16:08:01
Documents
7
Period of Report
2018-12-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-38204_88k.htm 8-K 98440
2 EX-3.1 a18-38204_8ex3d1.htm EX-3.1 11431
3 EX-3.2 a18-38204_8ex3d2.htm EX-3.2 8589
4 EX-10.1 a18-38204_8ex10d1.htm EX-10.1 113861
5 EX-10.5 a18-38204_8ex10d5.htm EX-10.5 20189
6 EX-99.1 a18-38204_8ex99d1.htm EX-99.1 21142
7 GRAPHIC g382047mmi001.jpg GRAPHIC 4281
  Complete submission text file 0001104659-18-072810.txt   281447
Mailing Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104
Business Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35890 | Film No.: 181233270
SIC: 2834 Pharmaceutical Preparations